Dr. Holtzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5150 Centre Avenue
Fl 4
Pittsburgh, PA 15232Phone+1 412-692-2852Fax+1 412-692-2520- Is this information wrong?
Summary
- Dr. Matthew Holtzman is a general surgeon in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Magee-Womens Hospital, UPMC Presbyterian Shadyside - Shadyside, UPMC Passavant, UPMC Presbyterian, and UPMC Presbyterian Shadyside - Shadyside. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 18 years. He specializes in surgical oncology (other than breast) and minimally invasive surgery and is experienced in minimally invasive surgery, endocrine surgery, surgical oncology (non-breast), colorectal surgery, and general / gastrointestinal surgery.
Education & Training
- Boston University Medical CenterResidency, Surgery, 1999 - 2004
- State University of New York Downstate Medical Center College of MedicineClass of 1999
Certifications & Licensure
- PA State Medical License 2004 - 2024
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- ASO Visual Abstract: Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from...Hamed, A., Derby, J., Jelinek, M., Tatsuoka, C., Choudry, M., Nunns, G., Holtzman, M., Zureikat, A., Ahrendt, S., Pingpank, J., Ongchin, M., Bartlett, D., Wach, M.> ;Annals of Surgical Oncology. 2024 Feb 14
- Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritonea...Hamed, A., Derby, J., Jelinek, M., Tatsuoka, C., Choudry, M., Nunns, G., Holtzman, M., Zureikat, A., Ahrendt, S., Pingpank, J., Ongchin, M., Bartlett, D., Wach, M.> ;Annals of Surgical Oncology. 2024 Apr 1
- ASO Visual Abstract: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusi...Ahmed B Hamed, Yongli Shuai, Joshua Derby, Matthew P Holtzman, Melanie Ongchin, David L Bartlett, James F Pingpank, Reetesh Pai, Aatur Singhi, Haroon A Choudry> ;Annals of Surgical Oncology. 2023 Jul 1
- Join now to see all
Journal Articles
- Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion Is Feasible and Offers Survival Benefit in Select Patients with Peritoneal MetastasesDavid L Bartlett, Filip Bednar, Reetesh K Pai, Heather L Jones, James F Pingpank, Matthew P Holtzman, Herbert J Zeh, Annals of Surgical Oncology
- Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal MalignanciesMatthew P Holtzman, James F Pingpank, David L Bartlett, Herbert J Zeh, Annals of Surgical Oncology
Professional Memberships
- Member
- Member
Hospital Affiliations
- UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
- UPMC PassavantPittsburgh, Pennsylvania
- Shadyside CampusPittsburgh, Pennsylvania
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: